相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults
Beth D. Kirkpatrick et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
S. R. Hadinegoro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Luis Villar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Virus-specific T lymphocytes home to the skin during natural dengue infection
Laura Rivino et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The Human CD8(+) T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes
Daniela Weiskopf et al.
JOURNAL OF VIROLOGY (2015)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding et al.
LANCET (2014)
T-cell immunity to infection with dengue virus in humans
Daniela Weiskopf et al.
FRONTIERS IN IMMUNOLOGY (2014)
A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Reduced Risk of Disease During Postsecondary Dengue Virus Infections
Sandra Olkowski et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9-16 Year Olds A Randomized, Controlled, Phase II Trial in Latin America
Luis A. Villar et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA
Gustavo H. Dayan et al.
VACCINE (2013)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Live-attenuated Tetravalent Dengue Vaccine in Dengue-naive Children, Adolescents, and Adults in Mexico City Randomized Controlled Phase 1 Trial of Safety and Immunogenicity
Jorge Poo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Development and clinical evaluation of multiple investigational monovalent DENV vaccines to identify components for inclusion in a live attenuated tetravalent DENV vaccine
Anna P. Durbin et al.
VACCINE (2011)
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes in Flavivirus-Naive Adults
Dennis Morrison et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
rDEN4Δ30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers
AP Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys
SS Whitehead et al.
VACCINE (2003)
分享论文
